Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annie Beaudry

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cancer Journal (Sudbury, Mass.)|September 20, 2017
DNA Methylation-Targeted DrugsElodie M Da Costa, Gabrielle McInnes, Annie Beaudry, et al.
Molecular Cancer Therapeutics|October 22, 2020
TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral ActivityJamilah Abusarah, Yun Cui, Nehme El-Hachem, et al.
Scientific Reports|September 30, 2023
Repurposing disulfiram, an alcohol-abuse drug, in neuroblastoma causes KAT2A downregulation and in vivo activity with a water/oil emulsionAnnie Beaudry, Simon Jacques-Ricard, Anaïs Darracq, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 15, 2019
Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylationElodie M Da Costa, Gregory Armaos, Gabrielle McInnes, et al.
Cancer Research|January 1, 2016
Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in CancerNoël J-M Raynal, Justin T Lee, Youjun Wang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cancer Journal (Sudbury, Mass.)|September 20, 2017
DNA Methylation-Targeted DrugsElodie M Da Costa, Gabrielle McInnes, Annie Beaudry, et al.
Molecular Cancer Therapeutics|October 22, 2020
TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral ActivityJamilah Abusarah, Yun Cui, Nehme El-Hachem, et al.
Scientific Reports|September 30, 2023
Repurposing disulfiram, an alcohol-abuse drug, in neuroblastoma causes KAT2A downregulation and in vivo activity with a water/oil emulsionAnnie Beaudry, Simon Jacques-Ricard, Anaïs Darracq, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 15, 2019
Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylationElodie M Da Costa, Gregory Armaos, Gabrielle McInnes, et al.
Cancer Research|January 1, 2016
Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in CancerNoël J-M Raynal, Justin T Lee, Youjun Wang, et al.
Pageof 1